{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-407331","form_type":"8-K","ticker":"LRMR","cik":"0001374690","company_name":"Larimar Therapeutics, Inc.","filed_at":"2026-09-29T20:06:32+00:00","discovered_at":"2026-09-29T20:08:00.592496+00:00","generated_at":"2026-10-12T13:53:34.796908+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Larimar Therapeutics names John B. Harlow Jr. President and COO; $560K salary, 850K-share equity grant","bullets":["Harlow, 51, was most recently Chief Commercial Officer at Esperion Therapeutics (Nov 2025-Sep 2026); earlier CCO roles at Melinta Therapeutics, Baudax Bio and Recro Pharma.","Employment effective September 29, 2026: base salary $560,000 per year, $35,000 cash signing bonus, target annual bonus of 40% of salary (2026 prorated).","Inducement awards under Nasdaq Rule 5635(c)(4): 800,000 stock options struck at the Sept 29, 2026 closing price and 50,000 restricted stock units.","Options vest 25% on the first anniversary and the remaining 75% in 36 monthly installments; RSUs vest in four equal annual installments beginning on the first anniversary.","Severance if terminated without cause: 9 months of salary plus 9 months COBRA; 12 months of salary plus target bonus and COBRA if terminated within one year after a change in control."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-407331","json":"https://secwatch.observer/filing/0001193125-26-407331.json","markdown":"https://secwatch.observer/filing/0001193125-26-407331.md","text":"https://secwatch.observer/filing/0001193125-26-407331.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1374690/000119312526407331/0001193125-26-407331-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1374690/000119312526407331/lrmr-20260929.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T13:53:34.796908+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}